Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/25/2025 | $120.00 → $115.00 | Outperform → Strong Buy | Raymond James |
| 12/4/2024 | $126.00 | Outperform | Mizuho |
| 11/15/2024 | $108.00 | Neutral | Goldman |
| 4/4/2024 | $101.00 | Mkt Outperform | JMP Securities |
| 4/2/2024 | $86.00 → $108.00 | Overweight | JP Morgan |
| 1/3/2024 | $84.00 | Overweight | Barclays |
| 9/21/2023 | $79.00 → $87.00 | Neutral → Outperform | Robert W. Baird |
| 10/21/2022 | $64.00 → $77.00 | Sell → Neutral | Goldman |
10-K - HEALTHEQUITY, INC. (0001428336) (Filer)
8-K - HEALTHEQUITY, INC. (0001428336) (Filer)
8-K - HEALTHEQUITY, INC. (0001428336) (Filer)
4 - HEALTHEQUITY, INC. (0001428336) (Issuer)
4 - HEALTHEQUITY, INC. (0001428336) (Issuer)
4 - HEALTHEQUITY, INC. (0001428336) (Issuer)
SC 13G/A - HEALTHEQUITY, INC. (0001428336) (Subject)
SC 13G/A - HEALTHEQUITY, INC. (0001428336) (Subject)
SC 13G/A - HEALTHEQUITY, INC. (0001428336) (Subject)
Highlights of the fiscal year include: Revenue of $1.20 billion, an increase of 20% compared to $999.6 million in FY24.Net income of $96.7 million, an increase of 74% compared to $55.7 million in FY24, with non-GAAP net income of $277.3 million, an increase of 42% compared to $195.5 million in FY24.Net income per diluted share of $1.09, an increase of 70% compared to $0.64 in FY24, with non-GAAP net income per diluted share of $3.12, an increase of 39% compared to $2.25 in FY24.Adjusted EBITDA of $471.8 million, an increase of 28% compared to $369.2 million in FY24.9.9 million HSAs, an increase of 14% compared to FY24.Total HSA Assets of $32.1 billion, an increase of 27% compared to F
DRAPER, Utah, March 18, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity") HealthEquity, the nation's largest Health Savings Account (HSA) administrator, today announced the launch of HealthEquity Assist™, a suite of tools that help members save, spend, and invest for healthcare. By using HealthEquity Assist, employers are enabled with greater visibility into their benefits program performance and can drive positive financial and health actions to support their workforce. The smart technology offering was developed to alleviate common employee pain points with their benefits — including rising healthcare costs, which are expected to increase by 9% in 20251, a comple
DRAPER, Utah, Feb. 27, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity"), the nation's leader in health savings accounts (HSAs) and consumer-directed benefits administration, has been named one of America's Dream Employers for 2025 by Forbes and one of the Best Companies to Work For in 2025 by U.S. News & World Report. These awards are the latest in a long run of accolades that recognize the company's ongoing commitment to its team and culture. "These awards validate our dedication to creating a workplace where our team can thrive and be part of our mission to save and improve lives by empowering healthcare consumers," said HealthEquity Vice President of People Exp
DRAPER, Utah, Feb. 18, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced its HSAs, HSA Assets and Total Accounts as of its fiscal year ended January 31, 2025. The Company also affirmed its guidance for fiscal 2025 and 2026, provided an updated HSA cash repricing schedule, and announced upcoming events and presentations. The total number of HSAs as of January 31, 2025 was 9.9 million, an increase of 14%, from 8.7 million as of January 31, 2024. The Company closed its fiscal year 2025 with 17.0 million Total Accounts, an increase of 9%, from 15.7 million as of January 31,
DRAPER, Utah, Jan. 13, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced estimates of HSAs, HSA Assets and Total Accounts for its fiscal year ending January 31, 2025, reflecting a strong sales year with record New HSAs from Sales and strong custodial HSA Asset growth. Estimated HSAs to be approximately 9.8 million by January 31, 2025, up from 8.7 million a year earlier.Estimated HSA Assets to be approximately $31 billion, up from $25.2 billion at the end of fiscal year 2024, with approximately $17 billion of HSA Cash. Invested balances included in the estimated assets a
DRAPER, Utah, Aug. 21, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity"), the leader in health savings accounts (HSAs) and consumer-directed benefits administration, will kick off the second annual HSA WeekTM on August 26. The weeklong event will include a variety of resources to educate workers and companies about HSAs and their potential to improve healthcare savings and financial stability. According to a recent HealthEquity research study, roughly 40% of employees lack confidence in their health plan decisions and more than half wonder at times if they have chosen the right plan for their needs. The good news is that education can help. The study also found th
Highlights of the fiscal year include: Revenue of $1.20 billion, an increase of 20% compared to $999.6 million in FY24.Net income of $96.7 million, an increase of 74% compared to $55.7 million in FY24, with non-GAAP net income of $277.3 million, an increase of 42% compared to $195.5 million in FY24.Net income per diluted share of $1.09, an increase of 70% compared to $0.64 in FY24, with non-GAAP net income per diluted share of $3.12, an increase of 39% compared to $2.25 in FY24.Adjusted EBITDA of $471.8 million, an increase of 28% compared to $369.2 million in FY24.9.9 million HSAs, an increase of 14% compared to FY24.Total HSA Assets of $32.1 billion, an increase of 27% compared to F
Highlights of the third quarter include: Revenue of $300.4 million, an increase of 21% compared to $249.2 million in Q3 FY24.Net income of $5.7 million, compared to $14.7 million in Q3 FY24, with non-GAAP net income of $69.4 million, an increase of 33% compared to $52.2 million in Q3 FY24.Net income per diluted share of $0.06, compared to $0.17 in Q3 FY24, with non-GAAP net income per diluted share of $0.78, compared to $0.60 in Q3 FY24.Adjusted EBITDA of $118.2 million, an increase of 24% compared to $95.6 million in Q3 FY24.9.5 million HSAs, an increase of 15% compared to Q3 FY24.Total HSA Assets of $30.0 billion, an increase of 33% compared to Q3 FY24.16.5 million Total Accounts, inc
DRAPER, Utah, Nov. 12, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced that after leading the company for more than 15 years, Jon Kessler, President and Chief Executive Officer, has decided to retire effective January 6, 2025. Mr. Kessler will remain a director and act a special advisor to the Company through April 30, 2025. To succeed Mr. Kessler, the Company announced the appointment of Scott Cutler, who will join HealthEquity as President and CEO and as a director effective January 6, 2025. HealthEquity management will host a conference call for investors on Tues
Raymond James upgraded HealthEquity from Outperform to Strong Buy and set a new price target of $115.00 from $120.00 previously
Mizuho initiated coverage of HealthEquity with a rating of Outperform and set a new price target of $126.00
Goldman initiated coverage of HealthEquity with a rating of Neutral and set a new price target of $108.00